SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Citibank, N.A./ADR – ‘F-6’ on 4/27/11 re: Shire plc

On:  Wednesday, 4/27/11, at 2:35pm ET   ·   Accession #:  1193805-11-808   ·   File #:  333-173744

Previous ‘F-6’:  ‘F-6’ on 4/15/11   ·   Next:  ‘F-6’ on 4/27/11   ·   Latest:  ‘F-6/A’ on 3/15/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 4/27/11  Citibank, N.A./ADR                F-6                    3:318K Shire plc                         E-Data Systems, Inc./FA

Registration of Depositary Shares Evidenced by American Depositary Receipts (Not Effective Immediately)   —   Form F-6
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: F-6         Registration of Depositary Shares Evidenced by      HTML     71K 
                          American Depositary Receipts (Not                      
                          Effective Immediately)                                 
 2: EX-99.(A)   Miscellaneous Exhibit                               HTML    122K 
 3: EX-99.(D)   Miscellaneous Exhibit                               HTML     14K 


F-6   —   Registration of Depositary Shares Evidenced by American Depositary Receipts (Not Effective Immediately)


This is an HTML Document rendered as filed.  [ Alternative Formats ]



  Unassociated Document  
 
Registration No. 333  -   
As filed with the  Securities and Exchange Commission on April 27, 2011


SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

FORM F-6
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933 FOR AMERICAN DEPOSITARY SHARES EVIDENCED BY
AMERICAN DEPOSITARY RECEIPTS
SHIRE PLC
(Exact name of issuer of deposited securities as specified in its charter)
N/A
(Translation of issuer’s name into English)
Jersey, Channel Islands
(Jurisdiction of incorporation or organization of issuer)
CITIBANK, N.A.
(Exact name of depositary as specified in its charter)
399 Park Avenue
New York, New York  10043
(212) 816-6690
(Address, including zip code, and telephone number, including area code, of depositary’s principal executive offices)
Shire Pharmaceuticals Inc.
725 Chesterbrook Boulevard
(484) 595-8800
(Address, including zip code, and telephone number, including area code, of agent for service)

Copies to:
 
John B. Meade
Davis Polk & Wardwell LLP
99 Gresham Street
London, EC2V 7NG
011-44-207-418-1011
 
Herman H. Raspé, Esq.
Patterson Belknap Webb & Tyler LLP
1133 Avenue of the Americas
(212) 336-2301

It is proposed that this filing become effective under Rule 466:
 
o  immediately upon filing.
o  on (Date) at (Time).
 
 
If a separate registration statement has been filed to register the deposited shares, check the following box : o

CALCULATION OF REGISTRATION FEE
 
Title of Each Class of
Securities to be Registered
Amount to be
Registered
Proposed Maximum
Aggregate Price Per Unit*
Proposed Maximum
Aggregate Offering Price**
Amount of
Registration Fee
American Depositary Shares, each representing three (3) ordinary shares of SHIRE plc.
100,000,000 American Depositary Shares
$5.00
$5,000,000
$580.50
 
*
Each unit represents 100 American Depositary Shares.
**
Estimated solely for the purpose of calculating the registration fee.  Pursuant to Rule 457(k), such estimate is computed on the basis of the maximum aggregate fees or charges to be imposed in connection with the issuance of American Depositary Shares.
 
The Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, or until this Registration Statement shall become effective on such date as the Commission, acting pursuant to said Section 8(a), may determine.
 
 
 

 
 
This Registration Statement may be executed in any number of counterparts, each of which shall be deemed an original, and all of such counterparts together shall constitute one and the same instrument.
 
 
ii 

 
 
PART I
 
INFORMATION REQUIRED IN PROSPECTUS
 
Cross Reference Sheet
 
Item 1.    DESCRIPTION OF SECURITIES TO BE REGISTERED
 
       
Location in Form of American
       
Depositary Receipt (“Receipt”)
Item Number and Caption
 
Filed Herewith as Prospectus
           
1.
Name of Depositary and address of its principal executive office
 
Face of Receipt -  Introductory Article.
         
2.
Title of Receipts and identity of deposited securities
 
Face of Receipt  - Top Center.
         
Terms of Deposit:
     
       
 
(i)
The amount of deposited securities represented by one American Depositary Share (“ADSs”)
 
Face of Receipt  - Upper right corner.
           
 
(ii)
The procedure for voting, if any, the deposited securities
 
Reverse of Receipt  - Paragraph (12).
           
 
(iii)
The collection and distribution of dividends
 
Face of Receipt – Paragraphs (4), (5) and (7)
Reverse of Receipt - Paragraphs (10) and (11).
           
 
(iv)
The transmission of notices, reports and proxy soliciting material
 
Face of Receipt  - Paragraphs (3), (5) and (8);
Reverse of Receipt - Paragraphs (12) and (13).
         
 
(v)
The sale or exercise of rights
 
Face of Receipt – Paragraphs (3), (4) and (5);
Reverse of Receipt – Paragraph (10).
           
 
(vi)
The deposit or sale of securities resulting from dividends, splits or plans of reorganization
 
Face of Receipt - Paragraphs (3), (4) and (5);
Reverse of Receipt - Paragraphs (10) and (13).
         
 
 
I-1

 
 
       
Location in Form of American
       
Depositary Receipt (“Receipt”)
Item Number and Caption
 
Filed Herewith as Prospectus
         
 
(vii)
Amendment, extension or termination of the deposit agreement
  Reverse of Receipt - Paragraphs (16) and (17).
         
  (viii) 
Rights of holders of Receipts to inspect the transfer books of the Depositary and the list of holders of ADSs
 
Face of Receipt - Paragraph (3).
         
 
(ix)
Restrictions upon the right to deposit or withdraw the underlying securities
 
Face of Receipt – Paragraphs (2), (3), (4), (5), (6) and (7);
Reverse of Receipt – Paragraph (10).
         
 
(x) 
Limitation upon the liability of the Depositary
 
Face of Receipt - Paragraph (5);
Reverse of Receipt - Paragraphs (10) and (14).
         
3. 
Fees and charges which may be imposed directly or indirectly on holders of ADSs
 
Face of Receipt - Paragraph (7).
       
Item 2.   AVAILABLE INFORMATION  
Face of Receipt - Paragraph (8).
 
The Company is subject to the periodic reporting requirements of the Securities Exchange Act of 1934 and accordingly files certain reports with, and submits certain reports to, the United States Securities and Exchange Commission (the “Commission”).  Such reports and other information can be retrieved from the Commission’s internet website (http://www.sec.gov), and can be inspected and copied at the public reference facilities maintained by the Commission at 100 F Street, N.E., Washington, D.C. 20549.
 
 
I-2

 
 
PROSPECTUS
 
The Prospectus consists of the proposed form of American Depositary Receipt included as Exhibit A to the Form of Amended and Restated Deposit Agreement filed as Exhibit (a) to this Registration Statement on Form F-6 and is incorporated herein by reference.
 
 
 
 
I-3

 
 
PART II
 
INFORMATION NOT REQUIRED IN PROSPECTUS
 
Item 3.    EXHIBITS
 
 
(a)
Form of Amended and Restated Deposit Agreement, by and among SHIRE plc (the “Company”), Citibank, N.A., as depositary (the “Depositary”), and all Holders and Beneficial Owners of American Depositary Receipts issued thereunder evidencing American Depositary Shares (“Deposit Agreement”).  ___ Filed herewith as Exhibit (a).
 
 
(b)
Any other agreement to which the Depositary is a party relating to the issuance of the American Depositary Shares registered hereunder or the custody of the deposited securities represented thereby.  ___ None.
 
 
(c)
Every material contract relating to the deposited securities between the Depositary and the issuer of the deposited securities in effect at any time within the last three years.  ___ None.
 
 
(d)
Opinion of counsel for the Depositary as to the legality of the securities to be registered.  ___ Filed herewith as Exhibit (d).
 
 
(e)
Certificate under Rule 466.  ___ None.
 
 
(f)
Powers of Attorney for certain officers and directors and the authorized representative of the Company.  ___ Set forth on the signature pages hereto.
 
 
II-1

 
 
Item 4.    UNDERTAKINGS
 
 
(a)
The Depositary undertakes to make available at the principal office of the Depositary in the United States, for inspection by holders of ADSs, any reports and communications received from the issuer of the deposited securities which are both (1) received by the Depositary as the holder of the deposited securities, and (2) made generally available to the holders of the underlying securities by the issuer.
 
 
(b)
If the amount of fees charged is not disclosed in the prospectus, the Depositary undertakes to prepare a separate document stating the amount of any fee charged and describing the service for which it is charged and to deliver promptly a copy of such fee schedule without charge to anyone upon request.  The Depositary undertakes to notify each registered holder of an ADS thirty (30) days before any change in the fee schedule.
 
 
II-2

 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Act of 1933, as amended, Citibank, N.A., acting solely on behalf of the legal entity to be created by the Amended and Restated Deposit Agreement, by and among SHIRE plc, Citibank, N.A., as depositary, and all Holders and Beneficial Owners from time to time of American Depositary Shares to be issued thereunder, certifies that it has reasonable grounds to believe that all the requirements for filing on Form F-6 are met and has duly caused this Registration Statement on Form F-6 to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of New York, State of New York, on the 27th day of April, 2011.
 
 
Legal entity to be created by the Amended and Restated Deposit Agreement under which the American Depositary Shares registered hereunder are to be issued, each American Depositary Share representing three (3) ordinary shares of SHIRE plc
 
CITIBANK, N.A., solely in its capacity as Depositary
 
       
 
By: 
/s/ Robert Franz  
    Name:   
    Title:
Vice President
 
 
 
II-3

 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Act of 1933, as amended, SHIRE plc certifies that it has reasonable grounds to believe that all the requirements for filing on Form F-6 are met and has duly caused this Registration Statement on Form F-6 to be signed on its behalf by the undersigned thereunto duly authorized, in Dublin, Ireland, on April 27, 2011.
 
 
SHIRE PLC
 
       
 
By: 
/s/ Angus Russell  
    Name:  Angus Russell  
    Title: Chief Executive Officer and Director  
 
 
II-4

 
 

 
POWERS OF ATTORNEY
 
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Angus Russell and Graham Hetherington, each of them acting individually, his true and lawful attorney-in-fact and agent, each with full power of substitution and resubstitution, for him and in his name, place and stead, in any and all such capacities, to sign any and all amendments, including post-effective amendments and supplements to this Registration Statement and any and all related registration statements pursuant to Rule 462(b) of the Securities Act of 1933, as amended, and to file the same, with all exhibits thereto and other documents in connection therewith, with the United States Securities and Exchange Commission, granting unto said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or any of them, or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
 
Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement on Form F-6 has been signed by the following persons in the following capacities on April 27, 2011.
 
Signature
 
Title
     
 
Non-Executive Chairman and Director
   
     
 
Chief Executive Officer and Director
 
(Principal Executive Officer)
     
 
Chief Financial Officer, Principal Accounting Officer and Director
Name: Graham Hetherington
 
 
     
 
Non-Executive Director
   
     
 
Non-Executive Director
   
 
 
II-5

 
 
Signature
 
Title
     
 
Non-Executive Director
   
     
 
Non-Executive Director
   
     
 
Non-Executive Director
   
     
 
Non-Executive Director
Name: Dr. David Ginsburg
   
     
 
Non-Executive Director
   
     
Authorized Representative in the U.S.
 
   
   


 
 
II-6

 
 
 
Exhibit
Document
Sequentially
Numbered Page
     
(a)
Form of Amended and Restated Deposit Agreement
 
     
(d)
Opinion of counsel to the Depositary
 


 

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘F-6’ Filing    Date    Other Filings
Filed on:4/27/118-K,  F-6
 List all Filings 
Top
Filing Submission 0001193805-11-000808   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 30, 9:33:48.1pm ET